Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2014 Filed Dec 2, 2014 20:34 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000196 · wf-form4_141755244227641.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,343 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 20:51 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000200 · wf-form4_141755346884700.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,982 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 20:53 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000202 · wf-form4_141755358238628.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,108 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 20:55 UTC |
HORN KAREN NDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000204 · wf-form4_141755370343020.xml · nonDerivative · entry 1 HORN KAREN N · CIK 0001136550 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,584 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 20:56 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000206 · wf-form4_141755380242503.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,978 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:01 UTC |
OBERHELMAN DOUGLAS RDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000210 · wf-form4_141755410104755.xml · nonDerivative · entry 1 OBERHELMAN DOUGLAS R · CIK 0001171770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,675 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 20:59 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000208 · wf-form4_141755397741552.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,728 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:03 UTC |
PRENDERGAST FRANKLYN GDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000212 · wf-form4_141755420857171.xml · nonDerivative · entry 1 PRENDERGAST FRANKLYN G · CIK 0001233256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,810 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:05 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000214 · wf-form4_141755433581244.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:07 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000216 · wf-form4_141755446830006.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,913 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:10 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000218 · wf-form4_141755459082446.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,464 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:37 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000220 · wf-form4_141755623733494.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,593 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 9,789 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · derivative · entry 7 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,789 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 8,787 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · derivative · entry 6 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,787 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Tax withholdingCommon Stock | 8,752 | $67.78 | $593,210.56 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,436 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionCommon Stock | 9,789 | $56.18 | $549,946.02 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Tax withholdingCommon Stock | 7,796 | $67.78 | $528,412.88 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,399 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionCommon Stock | 8,787 | $55.65 | $488,996.55 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2014 Filed Jan 29, 2015 18:26 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000009 · wf-form5_142255599923302.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,850 Read SEC document |
| November 13, 2014 Filed Nov 14, 2014 16:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,000 | $67.73 | $13,546,000.00 |
DisclosureSEC source: 0001209191-14-068726 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,775,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.42 to $68.00, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 11, 2014 Filed Nov 12, 2014 17:55 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 750 | $68.49 | $51,367.50 |
DisclosureSEC source: 0000059478-14-000187 · wf-form4_141581489703980.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,047 Read SEC document |
| November 07, 2014 Filed Nov 12, 2014 17:37 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 21,302 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000185 · wf-form4_141581383492359.xml · derivative · entry 4 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,302 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2014 Filed Nov 12, 2014 17:37 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Tax withholdingCommon Stock | 19,254 | $66.96 | $1,289,247.84 |
DisclosureSEC source: 0000059478-14-000185 · wf-form4_141581383492359.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,160 Read SEC document |
| November 07, 2014 Filed Nov 12, 2014 17:37 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Exercise / conversionCommon Stock | 21,302 | $55.65 | $1,185,456.30 |
DisclosureSEC source: 0000059478-14-000185 · wf-form4_141581383492359.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 19:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 180,000 | $67.00 | $12,060,000.00 |
DisclosureSEC source: 0001209191-14-066951 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,975,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.76 to $67.46, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 04, 2014 Filed Nov 6, 2014 20:43 UTC |
Walsh Fionnuala MSVP, Global Quality
|
SaleCommon Stock | 15,000 | $67.00 | $1,005,000.00 |
DisclosureSEC source: 0000059478-14-000183 · wf-form4_141530660022468.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,493 Read SEC document |
| November 03, 2014 Filed Nov 4, 2014 20:08 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $66.03 | $330,150.00 |
DisclosureSEC source: 0000059478-14-000181 · wf-form4_141513169758618.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,736 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 29, 2014. Read SEC document |
| October 31, 2014 Filed Oct 31, 2014 18:08 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 136 | $63.10 | $8,581.60 |
DisclosureSEC source: 0000059478-14-000177 · wf-form4_141477889005972.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Read SEC document |
| October 31, 2014 Filed Nov 3, 2014 20:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,399 | $67.01 | $629,826.99 |
DisclosureSEC source: 0001209191-14-065770 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,155,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.93 to $67.10, inclusive. Read SEC document |
| October 31, 2014 Filed Nov 3, 2014 20:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 180,601 | $66.37 | $11,986,488.37 |
DisclosureSEC source: 0001209191-14-065770 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,165,203 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.93 to $66.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 5,271 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · derivative · entry 11 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 0 Underlying: Common Stock · 5,271 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 5,680 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · derivative · entry 10 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 0 Underlying: Common Stock · 5,680 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 9,586 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · derivative · entry 9 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,586 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
SaleCommon Stock | 7,376 | $66.58 | $491,094.08 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 7 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 14,209 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 2,994 | $66.80 | $199,999.20 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 6 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 21,585 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 5,271 | $56.18 | $296,124.78 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 5 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 24,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 5,680 | $55.65 | $316,092.00 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 4 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 19,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 8,739 | $66.80 | $583,765.20 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 2 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,493 Read SEC document |
| October 31, 2014 Filed Nov 4, 2014 20:05 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 9,586 | $55.65 | $533,460.90 |
DisclosureSEC source: 0000059478-14-000179 · wf-form4_141513153843265.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2014 Filed Oct 31, 2014 19:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,900 | $66.94 | $328,006.00 |
DisclosureSEC source: 0001209191-14-065535 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,345,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.93 to $66.96, inclusive. Read SEC document |
| October 30, 2014 Filed Oct 31, 2014 19:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 170,100 | $66.57 | $11,323,557.00 |
DisclosureSEC source: 0001209191-14-065535 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,350,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.93 to $66.92, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 29, 2014 Filed Oct 31, 2014 18:03 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 127,811 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000176 · wf-form4_141477857451933.xml · derivative · entry 14 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 127,811 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2014 Filed Oct 31, 2014 18:03 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 118,097 | $64.83 | $7,656,228.51 |
DisclosureSEC source: 0000059478-14-000176 · wf-form4_141477857451933.xml · nonDerivative · entry 9 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,579 Read SEC document |
| October 29, 2014 Filed Oct 31, 2014 18:03 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 127,811 | $55.65 | $7,112,682.15 |
DisclosureSEC source: 0000059478-14-000176 · wf-form4_141477857451933.xml · nonDerivative · entry 8 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2014 Filed Oct 29, 2014 19:35 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 6,391 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000171 · wf-form4_141461130105127.xml · derivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,391 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2014 Filed Oct 29, 2014 19:35 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 5,612 | $66.05 | $370,672.60 |
DisclosureSEC source: 0000059478-14-000171 · wf-form4_141461130105127.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,045 Read SEC document |
| October 27, 2014 Filed Oct 29, 2014 19:35 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 6,391 | $55.65 | $355,659.15 |
DisclosureSEC source: 0000059478-14-000171 · wf-form4_141461130105127.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2014 Filed Oct 27, 2014 15:03 UTC |
Crowe Maria APresident, Mfg. Operations
|
SaleCommon Stock | 2,750 | $65.77 | $180,867.50 |
DisclosureSEC source: 0000059478-14-000166 · wf-form4_141442219515377.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,266 F1 · price: This transaction was executed in multiple trades at prices ranging from $65.76 to $65.78. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 06, 2014 Filed Oct 7, 2014 18:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 210,000 | $65.63 | $13,782,300.00 |
DisclosureSEC source: 0001209191-14-062287 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,520,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.40 to $65.94, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 03, 2014 Filed Oct 6, 2014 18:17 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,175 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000161 · wf-form4_141261946378941.xml · derivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,175 shares Expires 2014-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.